Literature DB >> 34131298

Estimation of potassium intake: single versus repeated measurements and the associated cardiorenal risk.

Rik H Olde Engberink1, Bert-Jan H van den Born2, Hessel Peters-Sengers3, Liffert Vogt4.   

Abstract

BACKGROUND: High potassium intake has been associated with lower blood pressure and a lower incidence of chronic kidney disease and cardiovascular events. In cohort studies, potassium intake is often estimated with a single 24-h urine collection. However, this may not represent actual long-term individual intake. We assessed whether a single baseline versus multiple follow-up measurements of 24-h urine potassium excretion results in different estimates of individual potassium intake and different associations between potassium intake and long-term outcome.
METHODS: We performed a retrospective cohort study in outpatient subjects with an estimated glomerular filtration rate >60 mL/min/1.73 m2 who had sampled a 24-h urine collection at baseline and had ≥1 collection during a 17-year follow-up. Potassium intake was estimated with a single baseline 24-h urine collection but also during 1-year, 5-year, and 15-year follow-up. We used cox regression analysis to assess the association between cardiorenal outcome and estimated potassium intake.
RESULTS: Average population (n = 541) 24-h potassium excretion was similar at baseline and follow-up but significant individual changes in potassium intake between baseline and follow-up were observed. Forty-four percent of the subjects switched between tertiles of estimated potassium intake when follow-up measurements were used instead of baseline measurements. Hazard ratios for renal and cardiovascular outcomes were 6.9 and 1.7 times higher when follow-up estimates of potassium intake were replaced by baseline estimates.
CONCLUSIONS: Estimated potassium intake and its association with long-term outcome change significantly when multiple follow-ups 24-h urine collections are used for estimation of potassium intake instead of a single baseline measurement.
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34131298     DOI: 10.1038/s41430-021-00951-0

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  1 in total

1.  Urinary sodium and potassium excretion and risk of cardiovascular events.

Authors:  Martin J O'Donnell; Salim Yusuf; Andrew Mente; Peggy Gao; Johannes F Mann; Koon Teo; Matthew McQueen; Peter Sleight; Arya M Sharma; Antonio Dans; Jeffrey Probstfield; Roland E Schmieder
Journal:  JAMA       Date:  2011-11-23       Impact factor: 56.272

  1 in total
  2 in total

1.  Urinary Potassium Excretion, Fibroblast Growth Factor 23, and Incident Hypertension in the General Population-Based PREVEND Cohort.

Authors:  Stanley M H Yeung; Ewout J Hoorn; Joris I Rotmans; Ron T Gansevoort; Stephan J L Bakker; Liffert Vogt; Martin H de Borst
Journal:  Nutrients       Date:  2021-12-17       Impact factor: 5.717

2.  Urinary potassium excretion and mortality risk in community-dwelling individuals with and without obesity.

Authors:  Stanley M H Yeung; Anne Nooteboom; Ewout J Hoorn; Joris I Rotmans; Liffert Vogt; Rudolf A de Boer; Ron T Gansevoort; Gerjan Navis; Stephan J L Bakker; Martin H De Borst
Journal:  Am J Clin Nutr       Date:  2022-09-02       Impact factor: 8.472

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.